Zydus Gets Us Fda Approval To Market Generic Colestipol Hcl Tablets
Zydus Lifesciences Ltd. (Formerly Known As Cadila Healthcare Ltd.) Has Received Final Approval From The Us Fda To Market Generic Colestipol Hydrochloride Tablets In The Strength Of 1Mg.Colestipol Hydrochloride Tablets Are Indicated As Adjunctive Therapy To Diet For The Reduction Of Elevated Serum Total And Ldl-C In Patients With Primary Hypercholesterolemia (Elevated Ldl-C) Who Do Not Respond Adequately To Diet. Colestipol Hydrochloride Is A Highly Complex Macro Molecule Drug Substance With Little Or No Systemic Absorption.Zydus
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!